The Hollies landed a major pay cheque for the use of their 70s classic 'The Air That I Breathe'.

Dwayne 'The Rock' Johnson says a 'Black Adam' sequel was dropped because it got caught in a "web of new leadership" at DC Studios and he doesn't understand the decision.

Billie Eilish dedicated her performance of 'Never Felt So Alone' to Angus Cloud at Lollapalooza, just days after his death.

Women in the US state with pregnancy complications will be exempted from the abortion ban, a judge rules.

A Texas judge issued an order late Friday temporarily barring the state from enforcing its ban on abortion after about six weeks of pregnancy in cases where a patient's life or health could be endangered by an "emergent medical condition."

The head of Florida's education department on Friday told school officials that Advanced Placement Psychology courses may be taught in their "entirety" after dizzying concerns over new state laws barring material on sexual orientation and gender identity.

The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,

While last summer was the season of the Hailey Bieber “glazed donut,” Sofia Richie’s embodiment of “quiet luxury” has become this year’s fashion obsession. However, the 24-year-old social media personality has revealed that she doesn’t consider herself to be the “queen” of the trend like so many people say she is. In a recent Who What Wear interview, Richie - now married to music executive Elliot Grainge - opened up about how she feels about the new title associated with her look. “Quiet luxury, the term, it sounds really nice, so I’m not knocking it,” she said. “But [my stylist] Liat Baruch and I started working together properly about three and a half years ago, and when we met, our word was ‘timeless.’” Baruch dressed the “it girl” for her April 2023 wedding in Antibes, France. The event has since been titled “a Chanel festival” and “this year’s royal wedding” by W Magazine and Vogue, respectively. During the ceremony, Richie wore a handful of custom couture designs for her welcome party, ceremony, and reception - all Chanel, of course. While speaking on the Who What Wear podcast with Hillary Kerr, Baruch spoke about the inspiration behind the lavish yet understated looks. “We were trying to elevate but stay young, be feminine, aspirational but also attainable - a little bit of everything while staying ageless and classic,” she remarked. “And we did that. She did that, too. It was a constant dialogue and true collaboration.” “She [Richie] was very clear on what she wanted and how she wanted to look: Not too overtly sexy, not too conservative,” Baruch added. “And she’s very focused on how she wants to dress in terms of style and her lifestyle in general, and we were very aligned with all of that.” The youngest daughter of Lionel Richie donned designs that were inspired by archival pieces, one of which Claudia Schiffer wore during a 1993 Chanel runway show. Other looks from the brand’s collection were showcased to fit the season and event theme. Richie’s desire to curate an effortless elegance in her personal style, especially for her wedding, has resonated with individuals striving for a “clean girl” aesthetic. While the A-lister’s closet may not reflect minimalism, her individual pieces are both simple and extravagant in the clever way that she styles them. Between structured blouses with ribbed flare pants and leopard print overcoats with cat-eye sunglasses, her outfits exemplify the perfect way to appear timeless and still have fun. Now, Richie has announced plans for her eponymous fashion line to capture her character in clothing. She intends to make the fashion brand accessible to fans of the put-together-but-without-trying look. “The aesthetic is very my vibe,” she admitted. “I made sure, trying on every single sample, that it embodies the aesthetic that I’ve been wearing. It’s 100 per cent me. No further details have been released about plans for the brand, other than that Richie will not be the fashion line. Read More Lionel Richie shares anti-ageing secrets after fans praise youthful appearance: ‘Sex will work also’ Sofia Richie opens up about early days of her relationship with Elliot Grainge Sofia Richie shows off ‘chic’ coronation concert outfit ahead of father Lionel Richie’s performance

Record-setting wildfires and deadly heat waves across the globe are providing the most tangible evidence of climate change

Yankees first baseman Anthony Rizzo was recently placed on the injured list. Here's what to know about his concussion timeline.On Thursday, the New York Yankees placed first baseman Anthony Rizzo on the 10-day injured list with post-concussion syndrome. The following is a brief description ...

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’

Mark Margolis, a veteran actor known for his performances on "Breaking Bad" and "Better Call Saul," has died, his son, actor and Knitting Factory Entertainment CEO Morgan Margolis, told The Hollywood Reporter.